Literature DB >> 22183897

Efficacy of tonsillectomy for pediatric patients with Dysphagia and tonsillar hypertrophy.

Daniel Clayburgh1, Henry Milczuk, Steve Gorsek, Nancy Sinden, Kandice Bowman, Carol MacArthur.   

Abstract

OBJECTIVE: To determine the effectiveness of tonsillectomy for the treatment of dysphagia related to tonsillar hypertrophy.
DESIGN: Prospective cohort study.
SETTING: Tertiary care pediatric otolaryngology practice. PARTICIPANTS: Eighty-five children aged 2 to 14 years referred for tonsillectomy owing to dysphagia related to tonsillar hypertrophy (dysphagia cohort) or for other indications (control cohort).
INTERVENTIONS: Swallowing Quality of Life (SWAL-QOL) dysphagia questionnaires were administered at the initial clinic visit, on the day of surgery, and at 1 month and 6 months after surgery. Patients were weighed on the day of surgery and at 1 month after surgery. MAIN OUTCOME MEASURES: The primary outcome measure was the SWAL-QOL score. Secondary outcome measures were the type of diet consistency patients tolerated at home and the weight percentile for age.
RESULTS: Of 85 patients enrolled, 57 went on to have surgery, completed at least 1 postoperative questionnaire, and were included in the data analysis. At 1 month after tonsillectomy, the dysphagia cohort (n = 18) demonstrated improved SWAL-QOL scores (mean [SD], 58.4 [4.8] before surgery vs 82.4 [5.3] after surgery; P < .001), more patients tolerating a regular diet (12 of 37 patients [33.3%] before surgery vs 22 of 36 [60.0%] after surgery, P = .01), and increased weight percentile for age (mean [SD], 36.5 [10.7] before surgery vs 50.0 [10.6] after surgery; P = .01). Similarly, at 1 month after tonsillectomy, the control cohort (n = 39) demonstrated improved SWAL-QOL scores (mean [SD], 80.8 [2.6] before surgery vs 91.7 [1.8] after surgery; P < .001), more patients tolerating a regular diet (30 of 37 patients [81.1%] before surgery vs 34 of 36 patients [94.4%] after surgery, P = .04), and increased weight percentile for age (mean [SD], 62.8 [5.4] before surgery vs 70.4 [5.1] after surgery; P = .003).
CONCLUSIONS: Dysphagia related to tonsillar hypertrophy is a significant problem not only among children with dysphagia with a primary complaint but also among a large subset of patients referred for tonsillectomy for other indications. Following tonsillectomy, both groups experience significant improvement in swallowing-related quality of life, ability to tolerate a regular diet, and weight percentile for age. Tonsillectomy is an effective treatment for the management of dysphagia related to tonsillar hypertrophy in children.

Entities:  

Mesh:

Year:  2011        PMID: 22183897     DOI: 10.1001/archoto.2011.196

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  5 in total

Review 1.  Systematic Review: Non-Instrumental Swallowing and Feeding Assessments in Pediatrics.

Authors:  Dani-Ella Heckathorn; Renée Speyer; Jessica Taylor; Reinie Cordier
Journal:  Dysphagia       Date:  2015-11-25       Impact factor: 3.438

Review 2.  Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis.

Authors:  Martin J Burton; Paul P Glasziou; Lee Yee Chong; Roderick P Venekamp
Journal:  Cochrane Database Syst Rev       Date:  2014-11-19

3.  Clinical practice guideline: tonsillitis II. Surgical management.

Authors:  Jochen P Windfuhr; Nicole Toepfner; Gregor Steffen; Frank Waldfahrer; Reinhard Berner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

4.  Effects of Tonsil size on Pulmonary Function test Results after Tonsillectomy in Children.

Authors:  Mitra Samareh Fekri; Aliasghar Arabi Mianroodi; Hossein Shakeri; Narges Khanjani
Journal:  Iran J Otorhinolaryngol       Date:  2016-01

5.  Mastication and deglutition changes in children with tonsillar hypertrophy.

Authors:  Jaqueline Freitas de Souza; Tais Helena Grechi; Wilma Terezinha Anselmo-Lima; Luciana Vitaliano Voi Trawitzki; Fabiana Cardoso Pereira Valera
Journal:  Braz J Otorhinolaryngol       Date:  2013-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.